Glucotrack (GCTK) Preferred Stock Liabilities (2014 - 2018)
Glucotrack's (GCTK) quarterly Preferred Stock Liabilities came in at $13.4 million in Q3 2018, little changed YoY from $13.4 million in Q3 2017, and little changed on a QoQ basis from $13.4 million in Q2 2018.
Glucotrack (GCTK) Preferred Stock Liabilities (2014 - 2018) Analysis & Trends
Glucotrack (GCTK) has 5 years of Preferred Stock Liabilities data on file, last reported at $13.4 million in Q3 2018.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $13.4 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $13.4 million (changed 0.0% YoY) and the FY2017 annual result came in at $13.4 million, up 33.66% from the prior year.
- Preferred Stock Liabilities steadied at $13.4 million in Q3 2018, from $13.4 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $13.4 million in Q3 2017 to a low of $6.9 million in Q4 2015.
- A 5-year average of $10.6 million and a median of $10.9 million in 2016 frame the typical range for Preferred Stock Liabilities.
- Annual changes were most pronounced in 2015 — Preferred Stock Liabilities retreated 10.48% — and 2016, when it surged 44.75%.
- Tracing GCTK's Preferred Stock Liabilities over 5 years: stood at $7.7 million in 2014, then slipped by 10.48% to $6.9 million in 2015, then soared by 44.75% to $10.0 million in 2016, then jumped by 33.66% to $13.4 million in 2017, then changed by 0.0% to $13.4 million in 2018.
- The last three Preferred Stock Liabilities figures came in at $13.4 million (Q3 2018), $13.4 million (Q2 2018), and $13.4 million (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 13.42 Mn |
| Jun 30, 2018 | 13.42 Mn |
| Mar 31, 2018 | 13.42 Mn |
| Dec 31, 2017 | 13.42 Mn |
| Sep 30, 2017 | 13.42 Mn |
| Jun 30, 2017 | 12.88 Mn |
| Mar 31, 2017 | 11.67 Mn |
| Dec 31, 2016 | 10.04 Mn |
| Sep 30, 2016 | 9.77 Mn |
| Dec 31, 2015 | 6.94 Mn |
| Sep 30, 2015 | 7.12 Mn |
| Jun 30, 2015 | 7.12 Mn |
| Mar 31, 2015 | 7.39 Mn |
| Dec 31, 2014 | 7.75 Mn |